Product category:
Laboratory and scientific books and publishing
News Release from: Select Biosciences | Subject: Protein Biochips 2003
Edited by the Laboratorytalk Editorial
Team on 07 May 2003
Protein biochip market remains wide open
Market report is based on extensive primary and secondary research, including interviews with current and potential customers and interviews with company representatives
The protein biochip market is underserved, despite growing from $70 million in 2001 to $100 million in 2002, according to a new report by Select Biosciences Prepared in San Francisco by former BioInsights consultants, Protein Biochips 2003 presents a detailed market model and thorough analysis of the technologies and business strategies of 38 leading protein biochip companies
This article was originally published on Laboratorytalk on 2 Oct 2003 at 8.00am (UK)
Related stories
Proteomics market shows rapid growth
Market research report projects that the market will grow to more than $2.5 billion by 2008, a compound annual growth rate of more than 14%
Growing market for ADME and toxicology
According to a new report, the market for in vitro toxicology is expected to grow to more than $300 million by 2005
Protein Biochips 2003 projects that the market will grow to more than $400 million in 2007, a compound annual growth rate of more than 35%.
Protein Biochips 2003 is based on extensive primary and secondary research, including interviews with current and potential customers and interviews with company representatives.
This research provides the foundation for a market model built on 30 interlinked sets of projections.
Further reading
RNAi is the hottest technology in drug discovery
New report says that RNAi has the potential to revolutionise biology research and drug target discovery by evolving genomics from inferring correlation to determining causation
Start here when seeking screening compounds
Report provides single comprehensive source of information for pharma and biotech companies about suppliers of screening compounds for drug discovery
At the highest level, the market is divided into three different applications: (1) Drug target and biomarker discovery and validation, (2) Drug development, and (3) Clinical trials and diagnostics.
The first application identifies and discovers targets and/or biomarkers and validates them through additional experimentation.
The second application transforms the targets into potential therapeutics.
The third application identifies and monitors disease states and drug responses.
Each application is divided across two types of protein biochips: capture biochips and interaction biochips.
A capture biochip has immobilised capture agents that are used to capture target proteins, primarily for detection and quantification.
An interaction biochip has immobilised proteins or peptides that are used to identify function or to identify interactions with other proteins or with lipids or small molecules.
Each type of biochip is divided into five subsections: price per biochip, number of biochips sold, price per hardware systems, number of hardware systems sold, and service revenue.
The complete model reveals a multitude of information about the biochip market, including market size by application, by biochip type, by components, and by business model.
The complete model also reveals unit sales and average pricing of capture and interaction biochips and their respective hardware systems.
In addition to the detailed market model, Protein Biochips 2003 evaluates the strengths and weaknesses of each of the protein biochip makers, and assesses both opportunities and threats facing their products.
Protein Biochips 2003 identifies the companies most likely to dominate specific market segments, as well as the companies most likely to play key supporting roles in moving technologies forward.
• Select Biosciences: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
